Clinical Trial Update: The Influence of Smoking Status on Prasugrel and Clopidogrel Treated Subjects Taking Aspirin and Having Stable Coronary Artery Disease [Phase 4]

View source ↗

Summary

Phase 4 trial examining how smoking status affects outcomes in patients with stable coronary artery disease treated with prasugrel or clopidogrel plus aspirin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Aspirin (Aspirin)
• CLOPIDOGREL (CLOPIDOGREL)
• PRASUGREL (prasugrel)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2012-12-12